NCI-FDA Panel Will Publish Draft Guidelines On Cancer Assay Development
This article was originally published in The Gray Sheet
Executive Summary
FDA Division of Clinical Laboratory Devices Director Steve Gutman is serving on a National Cancer Institute panel that will issue draft guidelines on cancer marker and assay development and publication of studies by early 2002